Your browser doesn't support javascript.
loading
Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment.
Riedel, Tina; Demaria, Olivier; Zava, Olivier; Joncic, Ana; Gilliet, Michel; Dyson, Paul J.
Affiliation
  • Riedel T; Laboratory of Organometallic and Medicinal Chemistry, Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology (EPFL) , 1015 Lausanne, Switzerland.
  • Demaria O; Department of Dermatology, University Hospital of Lausanne , 1011 Lausanne, Switzerland.
  • Zava O; Laboratory of Organometallic and Medicinal Chemistry, Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology (EPFL) , 1015 Lausanne, Switzerland.
  • Joncic A; Department of Dermatology, University Hospital of Lausanne , 1011 Lausanne, Switzerland.
  • Gilliet M; Department of Dermatology, University Hospital of Lausanne , 1011 Lausanne, Switzerland.
  • Dyson PJ; Laboratory of Organometallic and Medicinal Chemistry, Institute of Chemical Sciences and Engineering, Swiss Federal Institute of Technology (EPFL) , 1015 Lausanne, Switzerland.
Mol Pharm ; 15(1): 116-126, 2018 01 02.
Article in En | MEDLINE | ID: mdl-29185769

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Skin Neoplasms / Drug Repositioning / Melanoma / Antifungal Agents Limits: Animals Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2018 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Skin Neoplasms / Drug Repositioning / Melanoma / Antifungal Agents Limits: Animals Language: En Journal: Mol Pharm Journal subject: BIOLOGIA MOLECULAR / FARMACIA / FARMACOLOGIA Year: 2018 Type: Article Affiliation country: Switzerland